MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$129,061K
Unrealized gain on
investments
$407K
Net loss
-$129,468K
Other income, net
$13,536K
Loss from operations
-$143,004K
Total operating
expenses
$143,004K
Research and development
$109,818K
General and
administrative
$33,186K
Back
Back
Income Statement
source: myfinsight.com
Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. (ORIC)